Joshua Lehrer-Graiwer, Chief Medical Officer at Global Blood Therapeutics, Inc. (GBT), sold 22,523 shares at $60.00 ($1.4M) on 2019-11-25, disclosed to the SEC on 2019-11-27.
Open-market sale of $1.4M GBT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 298 | $18K | 1.2% |
| 2 | $60.00 | 312 | $19K | 1.3% |
| 3 | $60.00 | 447 | $27K | 1.9% |
| 4 | $60.00 | 656 | $39K | 2.7% |
| 5 | $60.00 | 1,108 | $66K | 4.6% |
| 6 | $60.00 | 3,515 |
| $211K |
| 14.7% |
| 7 | $60.00 | 4,594 | $276K | 19.2% |
| 8 | $67.19 | 11,593 | $779K | 54.3% |
| Total | $63.70 avg | 22,523 | $1.4M | 100% |
| Filing → |
| GBT | SELL | 2020-02-10 | $614K | — | Filing → |
| GBT | SELL | 2020-02-04 | $383K | — | Filing → |
| GBT | SELL | 2020-01-29 | $111K | — | Filing → |